Webinars and Sponsored Roundtables — Register Now

Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.

Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications. 

Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.

Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

CAP Today Recommends

Improve triaging in the ED
A new assay delivers a higher standard of cardiac care

Improve triaging in the ED: A new assay delivers a higher standard of cardiac care. “Is it a heart attack, or something less serious?” Every day, thousands of symptomatic patients ask emergency department (ED) physicians that very question. Over the years, as diagnostic tools for acute myocardial infarction (AMI), commonly known as a heart attack, have advanced, physicians can provide increasingly accurate answers to that question. Unfortunately, diagnostic gaps still exist that can result in poor patient outcomes.

POC testing management and integration

Dec. 2, 2016—A new white paper from Orchard Software titled “Point-of-care Testing: The Great Boom Ahead” discusses the history of POC testing connectivity and shares specific case study savings and improvements associated with the adoption of a POC testing connectivity and management solution. Read the white paper.

What pharmacogenomics can make possible

Oct. 5, 2016—Clinical laboratories and pathology groups ought to master the emerging areas of pharmacodynamics and pharmacokinetics that open the door to a more personalized approach to drug prescribing, says a free (registration required) white paper published by Dark Daily. Read. By identifying drugs most likely to benefit a patient, assessing the likely dose response, potentially avoiding adverse reactions, and reducing unnecessary use of drugs, pharmacogenomics testing can help optimize treatment and reduce costs associated with complications or inappropriate utilization.

Learn about molecular testing for M. pneumoniae

Sept. 14, 2016—Donna Mayne, the microbiology, serology, and molecular laboratory manager at Sacred Heart Health System in Pensacola, Fla., outlines the clinical benefits of using molecular technology to detect Mycoplasma pneumoniae in a free program provided by Meridian Bioscience. Watch. In a separate presentation, Vicki Chalker, PhD, head of the respiratory and vaccine-preventable bacteria reference unit of Public Health England’s National Infection Service, discusses the importance of testing for M. pneumoniae and the diagnostic methodologies available. Meridian’s M. pneumoniae test

How Zika interferes with normal fetal development

Aug. 29, 2016—An Archives of Pathology & Laboratory Medicine study analyzes evidence from nine postmortem examinations and related studies of fetuses and infants with intrauterine Zika virus infection and microcephaly. Author David A. Schwartz, MD, concludes “the Zika virus has a strong predilection for cells of the fetal central nervous system following vertical transmission.” Read the early online release.

How pathologists can lead in value-based care

Aug. 19, 2016—Pathologists have an opportunity to thrive and be health care team leaders in the coming world of accountable and value-based care, Donald Karcher, MD, argues in a webinar that offers a sneak peek of a course that he will moderate at CAP16 in Las Vegas. View the free, 30-minute webinar (registration required).

IHC testing’s impact on skin cancer

May 18, 2016—A free webinar sponsored by Sigma-Aldrich will review the utility of immunohistochemical testing with markers such as S-100, SOX-10, Ber-Ep4, and HHV-8 in accurately diagnosing skin cancer and improving survival rates for patients with the disease. Register. Continuing education credits for pathologists and histotechnologists attending this webinar will be offered through the National Society of Histotechnology. The speaker, Jeff Gordon, has more than 15 years of IHC diagnostic experience and conducted more than two dozen NSH-approved workshops.

Managing molecular information in the lab

March 17, 2016—As molecular technology and personalized medicine increasingly becomes the default position for clinical diagnostics laboratories, these modalities place significant demands on laboratory information systems. That is where molecular information management systems come into the picture. A white paper from The Dark Report and Dark Daily examines how pathologists are using MIMS to handle the complex workflows of various molecular platforms and modalities.

How to improve infectious disease management

Feb. 17, 2016—Two microbiology leaders will take part in a live, online panel discussion, “Tackling the U.S. Healthcare System’s Infectious Disease Management Problem,” Feb. 23, noon Central time. They will explore approaches to reducing antibiotic resistance, rapidly identifying pathogens in their patients, and controlling infectious disease in the hospital and the community. One approach that will be covered is the role of advanced molecular diagnostics in the clinical microbiology laboratory. Register. Speakers at the online panel will be: Margret Oethinger,